We’ve built the largest community exclusively forthose who are actively funding UK-based lifescience companies.
Since launching in January 2023, the BioCapital Network has grown to a community of over 325 members - every single individual is investing in UK-based life science companies.
Our mission
All members of the BioCapital Network are invited to join our online community platform, built on Mighty.
Our platform is a safe space where we actively discuss industry news and share interesting deal flow, all in sector-specific spaces.
This platform offers a better way for the international life science investment ecosystem to connect and allows a more open sharing of opportunities with the overall aim of getting more UK-based companies funded.
Once a quarter, we host an informal social meet-up exclusively for members of the BioCapital Network. No professional services. No pitching companies. No students. Just investors.
These socials have no formal agenda and provide a relaxed and open forum for investors from across all areas of life sciences to develop meaningful relationships, share high-quality deal flow, open co-investment opportunities and enable discussions on the latest industry trends and challenges.
Once a month, BioCapital Network members are invited to join intimate meet-ups centred around specific themes within life sciences.
We invite selected members of our BioEntrepreneur Club to these, aiming for a 1:1 investor-to-founder ratio with around 10 - 20 attendees, enabling a more personal way for founders and investors to connect. These sessions enable exposure to new investment opportunities alongside discussions around sector trends and challenges.
Members can be based anywhere in the world but they must be actively backing UK-based life science companies. In fact, we’re proud to be building an international community of investors who all recognise the strength and potential of UK life sciences.
As of Q1 2025, over 37% of BioCapital Network members represent funds headquartered outside of the UK with 23% in Europe, 11% in North America and 3% in Asia - spanning a total of 20 countries.
Through joining the community, investors based outside of the UK can enhance their deal flow by gaining unparalleled access to high-quality investment opportunities in UK-based companies that are shared by other trusted BioCapital Network members.
Apply for membershipHugo Villanueva
"The BioCapital Network have done a tremendous job of becoming the meeting place for life science VCs in the UK. The events they organise are a great opportunity for VCs to catch up on deals, challenge and cross-pollinate theses, as well as useful to expand your professional network. The community is successfully challenging the existing paradigm that VC is an elitist, closed-off profession, hopefully turning it more equitable (no pun intended) and diverse"
Lee Lindley
"It’s been game changing joining the BioCapital Investor Network. The life sciences venture ecosystem is constantly evolving and investor appetite changes accordingly. Having an investor-only network where we can share deal flow, discuss opportunities, and debate market trends has been hugely value additive to me and in my opinion benefits the entire UK life sciences ecosystem as a whole."
Elisabetta Sakiotis
"As a fund with a domain-focus, it is incredibly handy to have a community where I can connect with investors that share the same focus and discuss relevant trends for my industry. The BioCapital network creates a close-knit environment to share deal flow and opinions on the market."
Ollie Hardick
"The BioCapital Network is a great community for Life Science investors at all career stages. They host a diverse range of events that provide a relaxed and informal setting for networking with investors and peers, while mixer events with founders spotlight early-stage innovations that are great for deal flow. The online platform is a valuable resource for sharing news and tapping into the community's wealth of experience. I look forward to engaging more with this supportive network"
Sign up for our monthly newsletter of upcoming events, recently published insights, member news and SEC updates.